Wall Street’s Top Analysts Upgrades, Downgrades & Initiations
$AAPL, $CVS, $PCLN, $TEVA, $WDAY
Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of Wall Streets top analysts upgrades, downgrades and initiations for Wednesday, as follows:
Apple Inc.’s (NASDAQ:AAPL) price target was raised to 180 from 150 at Guggenheim. That compares with a Wall Street consensus price at 140.91. The 52-wk trading range is 89.47 – 139.48.
CVS Health Inc. (NYSE:CVS) removed from the Merrill Lynch US 1 List, but the firm kept its Buy rating on the shares. The 52-wk trading range is 69.30 – 106.67. The Wall Street consensus target for the pharmacy chain is 86.34.
Priceline Inc.’s (NASDAQ:PCLN) target was raised to 1,900 from 1,800 at The Benchmark Company. That compares with a consensus price objective of 1174.66. The 52-wk trading range for the internet travel giant is 1148 – 1664.
Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) analysts downgraded to Hold from Buy at Argus. The 52-wk trading range for the generic drug maker is 31.90 – 59.35. The Wall Street consensus price target is 40.57.
Workday Inc.’s (NASDAQ:WDAY) price target was raised to 91 from 86 at Wedbush after reporting earnings. That compares to a Wall Street consensus target of 84.09. The shares were downgraded from Buy to Hold at Evercore ISI. The 52-wk trading range is 63.61 – 93.35.
Latest posts by Paul Ebeling (see all)
- Asia: Gold, USD, Crude Oil, Stocks & Commodities - August 20, 2019
- Ferrari (NYSE:RACE) to Introduce New GT Car in November - August 20, 2019
- Boris Johnson Tells Macron and Merkel Make a New Deal or We Leave Without One - August 19, 2019